findmyKOL

Irene Malaty, MD

Enriched profile

Barbara Padgett Dein Professor of Neurology; Chief, Movement Disorders; Director, Parkinson Foundation Center of Excellence and Tourette Association of America Center for Excellence · University of Florida

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Gainesville, FL · Southeast · United StatesSpecialtyNeurologyFocusNeurological disorders and treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Irene Malaty is Barbara Padgett Dein Professor of Neurology; Chief, Movement Disorders; Director, Parkinson Foundation Center of Excellence and Tourette Association of America Center for Excellence at University of Florida. OpenAlex indexes 221 publications with 9,307 citations (h-index 45); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 16 Oct 2026

Overview

Updated 16 Oct 2026

Irene Malaty, MD, is Barbara Padgett Dein Professor of Neurology at University of Florida (Norman Fixel Institute for Neurological Diseases). The public record shows 221 publications with 9,307 citations (h-index 45), centered on Neurological disorders and treatments, Obsessive-Compulsive Spectrum Disorders, Parkinson's Disease Mechanisms and Treatments. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 4 companies.

  • Most recent indexed publication: 2026 · Neurology and therapy
  • Top research focus: Neurological disorders and treatments
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 4 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Parkinson's Disease3 trialsDystonia1 trialTourette Syndrome1 trial

Research focus

OpenAlex concept fingerprint
Neurological disorders and treatmentsObsessive-Compulsive Spectrum DisordersParkinson's Disease Mechanisms and TreatmentsBotulinum Toxin and Related Neurological DisordersNeurological and metabolic disorders

Drugs & molecules

across trials, industry payments and publications
Vyalevgeneric · Carbidopa / levodopaClinical trials—Industry payments13Publications—Nuplazidgeneric · PimavanserinClinical trials—Industry payments4Publications—KcentraClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments21ACADIA Pharmaceuticals IncClinical trials—Industry payments4Sage Therapeutics, Inc.Clinical trials—Industry payments4University of FloridaClinical trials3Industry payments—CSL BehringClinical trials—Industry payments1Neuron23 Inc.Clinical trials1Industry payments—Parkinson's FoundationClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
221publications

Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.

9,307citations

Total citations across indexed works.

45h-index

Hirsch index (OpenAlex). i10-index 116.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
4companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    99.5%
    Neuromuscular Blocker99.5%
    Onabotulinumtoxina100%
    Part B, office-administered≥113 patients
  • Nervous system

    0.5%
    Aromatic Amino Acid Decarboxylation Inhibitor0.2%
    Carbidopa-Levodopa63%Carbidopa-Levodopa Er22%Rytary9%Carbidopa6%
    Part D<11 patients
    Atypical Antipsychotic0.1%
    Clozapine100%
    Part D<11 patients

    + 8 more classes in this area

  • Cardiovascular

    0%
    Central alpha-2 Adrenergic Agonist0%
    Clonidine Hcl100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Michael S. Okun115Ramon L. Rodriguez55Aparna Wagle Shukla32Kelly D. Foote29Joseph J. Jankovic22Genko Oyama21Hyder Azad Jinnah20Joel S. Perlmutter19Charles E. Jacobson19Wissam Deeb17Yulia Worbe16Brian D. Berman16Samuel Shangwu Wu16Andreas Hartmann15Hubert H. Fernandez15Kirsten Müller‐Vahl14Pamela Zeilman14Nikolaus R. McFarland14Davide Martino14Mark S. LeDoux14Hubert H. Fernandez14Marie Vidailhet13Peter N. Schmidt13Erica Greenberg13Jeremiah M. Scharf13Carol A. Mathews13Benjamin M. Neale12Joohi Jimenez Shahed12Sotirios Andreas Parashos12Emmanuel Flamand Roze12Cathy L. Barr12Marco A. Grados12Dongmei Yu12Chris J. Hass12Robert A. Hauser12Paul Sandor12Guy Armand Rouleau11Nelson Hwynn11Sabrina Michelle Darrow11Renata Rizzo11

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/irene-malaty-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/irene-malaty-14266466

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Member

    Science Committee, American Academy of Neurology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.ufl.edu ↗
  • Co-chair

    task force on tic disorder definition

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.ufl.edu ↗

Awards & honors

honors on the public record

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.